204 related articles for article (PubMed ID: 17286588)
1. Dopaminergic neurons intrinsic to the striatum.
Huot P; Parent A
J Neurochem; 2007 Jun; 101(6):1441-7. PubMed ID: 17286588
[TBL] [Abstract][Full Text] [Related]
2. L-Dopa treatment abolishes the numerical increase in striatal dopaminergic neurons in parkinsonian monkeys.
Huot P; Lévesque M; Morissette M; Calon F; Dridi M; Di Paolo T; Parent A
J Chem Neuroanat; 2008 Jan; 35(1):77-84. PubMed ID: 17706922
[TBL] [Abstract][Full Text] [Related]
3. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
Huot P; Lévesque M; Parent A
Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine hydroxylase cells appearing in the mouse striatum after dopamine denervation are likely to be projection neurones regulated by L-DOPA.
Darmopil S; Muñetón-Gómez VC; de Ceballos ML; Bernson M; Moratalla R
Eur J Neurosci; 2008 Feb; 27(3):580-92. PubMed ID: 18279311
[TBL] [Abstract][Full Text] [Related]
5. The ability of grafted human sympathetic neurons to synthesize and store dopamine: a potential mechanism for the clinical effect of sympathetic neuron autografts in patients with Parkinson's disease.
Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T
Exp Neurol; 2004 Jul; 188(1):65-73. PubMed ID: 15191803
[TBL] [Abstract][Full Text] [Related]
6. Tyrosine hydroxylase-positive neurons intrinsic to the human striatum express the transcription factor Nurr1.
Cossette M; Parent A; Lévesque D
Eur J Neurosci; 2004 Oct; 20(8):2089-95. PubMed ID: 15450088
[TBL] [Abstract][Full Text] [Related]
7. Denervation and repeated L-DOPA induce complex regulatory changes in neurochemical phenotypes of striatal neurons: implication of a dopamine D1-dependent mechanism.
St-Hilaire M; Landry E; Lévesque D; Rouillard C
Neurobiol Dis; 2005 Nov; 20(2):450-60. PubMed ID: 15896973
[TBL] [Abstract][Full Text] [Related]
8. Neurochemical characterization of dopaminergic neurons in human striatum.
Cossette M; Lévesque D; Parent A
Parkinsonism Relat Disord; 2005 Aug; 11(5):277-86. PubMed ID: 15970454
[TBL] [Abstract][Full Text] [Related]
9. Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease.
Joyce JN; Smutzer G; Whitty CJ; Myers A; Bannon MJ
Mov Disord; 1997 Nov; 12(6):885-97. PubMed ID: 9399211
[TBL] [Abstract][Full Text] [Related]
10. New striatal dopamine neurons in MPTP-treated macaques result from a phenotypic shift and not neurogenesis.
Tandé D; Höglinger G; Debeir T; Freundlieb N; Hirsch EC; François C
Brain; 2006 May; 129(Pt 5):1194-200. PubMed ID: 16481374
[TBL] [Abstract][Full Text] [Related]
11. Non-dopaminergic neurons partly expressing dopaminergic phenotype: distribution in the brain, development and functional significance.
Ugrumov MV
J Chem Neuroanat; 2009 Dec; 38(4):241-56. PubMed ID: 19698780
[TBL] [Abstract][Full Text] [Related]
12. Serotonin and dopamine striatal innervation in Parkinson's disease and Huntington's chorea.
Bédard C; Wallman MJ; Pourcher E; Gould PV; Parent A; Parent M
Parkinsonism Relat Disord; 2011 Sep; 17(8):593-8. PubMed ID: 21664855
[TBL] [Abstract][Full Text] [Related]
13. Morphology and distribution of dopaminergic neurons intrinsic to the human striatum.
Cossette M; Lecomte F; Parent A
J Chem Neuroanat; 2005 Jan; 29(1):1-11. PubMed ID: 15589697
[TBL] [Abstract][Full Text] [Related]
14. Sprouting of dopamine terminals and altered dopamine release and uptake in Parkinsonian dyskinaesia.
Lee J; Zhu WM; Stanic D; Finkelstein DI; Horne MH; Henderson J; Lawrence AJ; O'Connor L; Tomas D; Drago J; Horne MK
Brain; 2008 Jun; 131(Pt 6):1574-87. PubMed ID: 18487277
[TBL] [Abstract][Full Text] [Related]
15. [Expression of the enzymes of dopamine synthesis in non-dopaminergic neurons: functional significance and regulation].
Ugriumov MV
Usp Fiziol Nauk; 2007; 38(4):3-20. PubMed ID: 18064905
[TBL] [Abstract][Full Text] [Related]
16. Transplantation of autologous sympathetic neurons as a potential strategy to restore metabolic functions of the damaged nigrostriatal dopamine nerve terminals in Parkinson's disease.
Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T
Brain Res Rev; 2006 Sep; 52(2):244-56. PubMed ID: 16644019
[TBL] [Abstract][Full Text] [Related]
17. Sonic hedgehog and FGF8: inadequate signals for the differentiation of a dopamine phenotype in mouse and human neurons in culture.
Stull ND; Iacovitti L
Exp Neurol; 2001 May; 169(1):36-43. PubMed ID: 11312556
[TBL] [Abstract][Full Text] [Related]
18. A novel immunophilin ligand: distinct branching effects on dopaminergic neurons in culture and neurotrophic actions after oral administration in an animal model of Parkinson's disease.
Costantini LC; Chaturvedi P; Armistead DM; McCaffrey PG; Deacon TW; Isacson O
Neurobiol Dis; 1998 Aug; 5(2):97-106. PubMed ID: 9746907
[TBL] [Abstract][Full Text] [Related]
19. Dopamine receptor agonists reverse behavioral abnormalities of alpha-synuclein transgenic mouse, a new model of Parkinson's disease.
Wakamatsu M; Iwata S; Funakoshi T; Yoshimoto M
J Neurosci Res; 2008 Feb; 86(3):640-6. PubMed ID: 17896793
[TBL] [Abstract][Full Text] [Related]
20. SK channel function regulates the dopamine phenotype of neurons in the substantia nigra pars compacta.
Aumann TD; Gantois I; Egan K; Vais A; Tomas D; Drago J; Horne MK
Exp Neurol; 2008 Oct; 213(2):419-30. PubMed ID: 18680743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
